Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 3 boards, counting each seat separately. Longest: Palisade Bio Inc., 3 years.
Palisade Bio Inc.
Director
Processa Pharmaceuticals Inc.
Director
Akari Therapeutics plc
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Processa Pharmaceuticals Inc. July 30, 2026100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 26, 2026 | Processa Pharmaceuticals Inc. | Option exercise | +203 | — | — |
| Mar 31, 2026 | Processa Pharmaceuticals Inc. | Open-market purchase | +789 | $2.54 | $2,004 |
| Mar 6, 2025 | Akari Therapeutics plc | Grant or award | +4,464 | $1.12 | $5,000 |
| Jan 9, 2025 | Akari Therapeutics plc | Grant or award | +8,000,000 | — | — |
| Dec 23, 2024 | Akari Therapeutics plc | Grant or award | +2,000,000 | — | — |
| Feb 9, 2024 | Palisade Bio Inc. | Option exercise | +5,100 | — | — |
| Feb 9, 2024 | Palisade Bio Inc. | Option exercise | +5,820 | — | — |
| Jun 27, 2023 | Processa Pharmaceuticals Inc. | Option exercise | +14,407 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.